Abstract-Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized clinically by motor dysfunction (bradykinesia, rigidity, tremor, and postural instability), and pathologically by the loss of dopaminergic neurons in the substantia nigra of the basal ganglia. Growing literature supports that cognitive deficits may also be present in PD, even in non-demented patients. Gray matter (GM) atrophy has been reported in PD and may be related to cognitive decline. This study investigated cortical thickness in non-demented PD subjects and elucidated its relationship to cognitive impairment using high-resolution T1-weighted brain MRI and comprehensive cognitive function scores from 71 non-demented PD and 48 control subjects matched for age, gender, and education. Cortical thickness was compared between groups using a flexible hierarchical multivariate Bayesian model, which accounts for correlations between brain regions. Correlation analyses were performed among brain areas and cognitive domains as well, which showed significant group differences in the PD population. Compared to Controls, PD subjects demonstrated significant age-adjusted cortical thinning predominantly in inferior and superior parietal areas and extended to superior frontal, superior temporal, and precuneus areas (posterior probability >0.9). Cortical thinning was also found in the left precentral and lateral occipital, and right postcentral, middle frontal, and fusiform regions (posterior probability >0.9). PD patients showed significantly reduced cognitive performance in executive function, including set shifting (p ¼ 0.005) and spontaneous flexibility (p ¼ 0.02), which were associated with the above cortical thinning regions (p < 0.05).
replacement treatments, PD patients experience progressively more motor and non-motor disabilities, including cognitive, sensory, and emotional impairments [2] , [3] , [4] . Long-term follow-up studies have shown that 83 percent of PD patients suffer from dementia within 20 years of diagnosis [5] , [6] , [7] . Braak et al. [8] have hypothesized that the progression of a diverse sprectrum of motor and non-motor dysfunction is likely related to the ascending spread of a-synuclein-immunopositive Lewy bodies and neurites from lower brainstem nuclei to cortical gray areas. The cortical involvement of Lewy bodies in PD was postulated to initiate in the temporal mesocortex region (stage 4), continue to the prefrontal cortex (stage 5), and finally reach to the primary sensory and premotor areas (stage 6) [8] . Although it is still unclear whether Lewy bodies are the direct cause of neuronal degeneration, the pathological changes in the cortex may relate directly to cognitive impairment in PD.
Several in vivo functional neuroimaging studies of PD patients have been used to assess the neurodegenerative progression and their functional correlations in PD. For example, positron emission tomography (PET) studies have attempted to define abnormal covariance patterns of cortical and subcortical regional glucose metabolism that correlated with cognitive impairment [9] , [10] . FMRI studies revealed the relationship between cognitive impairments and reduced neural activity in frontostriatal circuitry [3] . These functional neurological assessments, however, may be influenced by symptomatic treatments and functional states of patients.
Structural volumetric measurements with high-resolution magnetic resonance imaging (MRI) may reflect in vivo macroscopic atrophy of the regions of interest (ROIs) and have been adopted to characterize the pathological process. Recent MRI studies using voxel-based morphometry (VBM) revealed a correlation of grey matter (GM) atrophy with disease stage and cognitive impairment in PD [11] , [12] , [13] . The results in non-demented PD were, however, more variable, with some studies reporting regional GM atrophy in frontal, temporal, or parietal cortex [14] . Conversely, some studies have shown no cortical atrophy in PD [15] , [16] . The variability of VBM results and the lack of a consistent portrait of damage in the cerebral cortex may be due partly to non-specific spatial smoothing that mixes voxels far apart on the plane (e.g., on different hemispheres or sides of a sulcus) [17] , [18] .
Cortical thickness measures the shortest distance between a given brain surface and inner edge of cortical gray matter and may more directly reflect the underlying cyto-and myeloarchitecture of cortical structural changes. For example, it has been shown that neurons within the cerebral cortex are organized into ontogenetic columns that run perpendicular to the brain surface [19] , and the cortical thickness measurement was linked to the number of cells within a column, reflecting the density of neuronal cell bodies and/or synaptic connections and the myelination of fibers [20] , [21] , [22] [23] . Thus, cortical thickness has been hypothesized to be a more promising tool to investigate GM changes related to PD cortical pathology. Consistent with this hypothesis, it has been demonstrated that cortical thinning occurs in both mild and advanced PD patients [24] , [25] , [26] [27] , and can be associated with disease duration. In addition, accelerated cortical thickness changes and cognitive impairment have been reported in PD patients older than 70 years of age [28] , [29] [30] . Studies in PD without dementia have reported cortical folding abnormalities and GM volume reductions [31] . However, it remains unclear whether there is any relationship with cognitive changes, and how cortical thickness is related to cognitive impairment in PD without dementia [32] .
In this study, we tested the hypothesis that changes in cortical thinning can be detected in PD patients without dementia and these changes are correlated with measured cognitive decline. We adopted an advanced hierarchical multivariate Bayesian model to analyze the cortical thickness measurement and thinning pattern, which can take regions' dependence into account using high resolution MRI on a large cohort of relatively younger PD patients without evidences of dementia. The basic analytic framework for the Bayesian model has been previously applied to fMRI data [33] , [34] , and here we extend it for the first time for the analysis of cortical thickness. In addition, we performed correlation analyses between cortical thickness and neuropsychological tests to assess the neural substrates of cognitive decline in PD.
MATERIALS AND METHODS

Participants
Patients with PD and control subjects (Controls) were recruited from an ongoing study approved by the Institutional Review Board/Human Subjects Protection Office (IRB/HSPO) of the Pennsylvanian State Hershey Medical Center. All participants provided written informed consent in accordance with IRB/HSPO guidelines and the Declaration of Helsinki.
Seventy-one PD patients without dementia were included in this study, who were diagnosed by a movement disorders specialist according to the published criteria [35] , and were optimally managed with anti-parkinsonian medications. 48 Controls matched with PD patients for age, gender, education, and handedness, were selected from a pool of controls that were part of the ongoing study. Controls were free from any history of neurologic or psychiatric disorder, including previous head injury. All subjects were negative for other neurological history, hypothyroidism, vitamin B12 and folate deficiencies, and kidney and liver disease. None of the PD or Controls were demented with MMSE > 25 and DRS-2 > 10 [36] , [37] .
For both motor and cognitive tests, PD patients were assessed in a practically defined "off" state after withholding all medications overnight ($12 hours) [38] . Unified Parkinson's Disease Rating Scale III (UPDRS) scores were recorded for all subjects and verified by a second rater from video recordings of the original assessment, except for rigidity. Disease severity was also recorded using Hoehn and Yahr staging [39] .
Cognitive Assessment
All subjects were administered a standardized neuropsychological battery, along with the Hamilton Depression Scale (HAM-D) [40] . Montreal Cognitive Assessment (MoCA) [41] and the Dementia Rating Scale, Second Edition (DRS-2) [36] . One fine motor function domain and six cognitive domains were examined [13] : (1) processing speed, (2) executive functions [set-shifting and spontaneous flexibility], (3) language, (4) learning/memory, (5) spatial cognition, and (6) attention/working memory. Each domain was assessed by two or more tests, except for the fine motor speed [13] .
Neuroimaging Data Acquisition and Preprocessing
MRIs were acquired on a Siemens Cortical thickness data were obtained using the FreeSurfer software package (version 5.3, available at: http:// surfer.nmr.harvard.edu). The automated procedures first include resampling T1W MR images, motion correction, removal of non-brain tissue via a hybrid surface deformation procedure [42] ; Second, automated Talairach transformation, segmentation of the subcortical white matter (WM) and deep GM volumetric structures were applied [43] ; Third is intensity normalization [44] ; And then, tessellation of the GM/WM boundary, automated topology correction [45] , and surface deformation following intensity gradients to place optimally the GM/WM and GM/cerebrospinal fluid borders at the location where the greatest shift in intensity defines the transition to the other tissue class [46] , [47] . Cortical thickness was measured at each vertex of the WM/GM boundary by computing the shortest distance toward the pial surface. Cortical thickness maps were smoothed using a Gaussian kernel across the surface with a FWHM of 10 mm and averaged across subjects.
STATISTICAL ANALYSES
MRI Thickness Analysis
We adopted a flexible multivariate Bayesian approach, based on an in-house hierarchical Bayesian model that enables the user to formulate probabilistic statements to quantify the evidence for cortical thickness differences between PD and Controls (http://web1.sph.emory.edu/ bios/ CBIS/download_page.php). We extend the previous formulation of the model for fMRI data [33] , [34] to analyze cortical thinning associated with PD. The hierarchical Bayesian model accounts for both spatial correlations between intra-regional voxels as well as between distinct cortical regions. Along the lines of Bowman et al. [33] , the Bayesian model has the following hierarchical structure:
. . . ; J index groups, and v g represents the number of voxels in a particular region indexed by g ¼ 1; . . . ; G with G as the total region number. We utilized the Desikan-Killiany Atlas regions from FreeSurfer, which included G ¼ 35 regions of interest and P G g¼1 n g ¼ 16; 384 voxels in each hemisphere [48] . In the model, g g gjq ¼ ðg gjq ð1Þ; . . . ; g gjq ðv g ÞÞ 0 is the v g Â 1 populationlevel parameter associated with the q th covariate x ijq , q ¼ 1; . . . ; Q where Q is the dimensionality of the covariates of interest. In particular, pairwise spatial correlations among the voxels within the g th region are mediated by the random effect a igj . At the second level, the model expresses a prior belief that each voxel's cortical thickness population mean arises from a normal distribution with a mean given by the overall region mean m 0gj , which is the empirical mean across all subjects and intra-regional voxels, and the variance 2 gj . It represents a reasonable starting point to assume that voxels' cortical thickness within anatomically defined regions deviate around an overall mean for that region. Similarly, for each voxel, g gjq follows a normal distribution with mean g 0gjq and variance t 2 gjq : At the final level, the hierarchical model captures potential group-related connectivity between brain regions through the covariance matrix G j , which follows the inverse Wishart distribution with the positive definite matrix H 0j as the inverse scale matrix. The Gamma and Wishart distributions are assumed in part due to mathematical/computational convenience. For gamma distribution, we usually set a vague prior (less weight) and have enough data points to estimate the variance well. In case of Whishart distribution, we use the hyper parameter based on the data sample in the same format Kass and Natarajan [49] suggested, with the identity link for the normal distribution. In addition, we also include the covariance structure shrinkage tuning parameter to adjust the strength of belief of between region correlations and implemented in the software [34] .
A Markov Chain Monte Carlo (MCMC) method with Gibbs sampling is performed for estimation, and the Gibbs sampling facilitates the estimation by providing substantial reductions in computing time and memory. We set weakly informative priors for the hyper-parameters a0 ¼ c0 ¼ e0q ¼ 0.1, b0 ¼ f0q ¼ 0.005, d0 ¼ 0.01, and h0 ¼ G (the total number of regions of interest), to ensure that the information in the data primarily governs the results [49] . The selection for h0 establishes a diffuse prior for the covariance matrix without raising concerns about an improper posterior distribution. More informative priors, however, may be employed when fairly precise information is available. The full conditional distribution for each parameter to run the Gibbs sampler is derived accordingly, which can be referred to Bowman et al. [33] . We performed 10,000 iterations with burn-in of 5,000 iterations and thinning of 10 iterations (for storage and computation time). Despite the apparent complexity and rather rich formulation of our Bayesian hierarchical model, as well as the high throughput nature of the data, computations for estimation are quite fast. For instance, estimation for the Bayesian hierarchical models for our data with 71 PD and 48 controls, the computation time is around one hour with our PC (two duo cores, 16G memory). The region-level parameters and voxel-level parameters showed evidence of convergence, after the burn-in period, in our MCMC analysis. We included age as a covariate in our Bayesian analysis. In preliminary analyses, age showed significant associations with average cortical thickness in each hemisphere with p-values less than 0.01 shown in Fig. 1 .
Neuropsychological Test Analysis
Two sample t-tests were used for group comparisons in demographic information and clinical characteristics (Table 1) .
For neuropsychological data, cognitive test scores first were converted to standardized z-scores and then cognitive domains analyzed using analysis of covariance (ANCOVA) with age and HAM-D scores as covariates. All analyses were performed using SAS 9.3 software (SAS Institute, Cary, NC).
Correlation Analysis between Cortical Thickness and Cognitive Tests
Additional correlation analyses were performed to assess the Spearman's partial correlations between cortical thinning regions within each brain hemisphere and the cognitive variables in both PD patients and Controls. This additional correlation analysis using Spearman's correlation can provide valid measures of their statistical dependence even if a non-linear relationship exists.
RESULTS
Demographics
From 
Cortical Thickness Analysis
The average total left and right cerebral cortical thicknesses for PD patients were 2.25 AE 0.17 mm and 2.24 AE 0.16 mm, respectively, whereas these of the healthy controls were 2.30 AE 0.11 mm and 2.29 AE 0.11 mm, respectively. As shown in Fig. 1 , overall decline of cortical thickness was shown with aging in both Control and PD groups, but this association only achieved statistical significance in the PD group [29] . Fig. 2 shows the cortical thickness differences between PD patients and Controls using the Bayesian hierarchical model with the posterior probability threshold level set at 0.9, i.e., the posterior probability that cortical thickness for PD patients is less than controls, Pr(PD < Control) ¼ 0.9. The thresholded posterior probability maps reveal voxels for which the data provide evidence of cortical thinning in the PD compared with Controls. PD subjects demonstrated significant cortical thinning in the superior temporal and inferior and superior parietal areas that extended to superior frontal and precuneus regions. Cortical thinning also was found in the left precentral and lateral occipital, and the right postcentral, middle frontal, and fusiform regions. Table 2 gives out the regions information with the posterior probability over 0.9, such as regions' name, coordinates, and size.
Considering the potential group-related connectivity between brain regions through the covariance matrix G j , Fig. 3 shows the posterior median of the correlation matrices for both the control and PD groups in the left and right hemisphere. As expected, larger degrees of inter-regional connectivity regions were found in superior temporal and inferior and superior parietal to frontal and precuneus regions, to reflect that these affected regions have a stronger inter-regional functional connectivity among the PD group.
Cognitive Tests
Three PD patients who did not complete parts of the full neuropsychological battery were excluded from this analysis. Table 3 shows that PD subjects performed significantly lower than Controls on tasks related to fine motor speed (p < 0:001), processing speed (p ¼ 0:002), set-shifting (p ¼ 0:005), spontaneous flexibility (p ¼ 0:02), and attention (p ¼ 0.03). Language, learning/memory, and spatial cognition domains failed to show group differences (p > 0:05). Here the raw p-values are obtained based on two-sample t tests and the adjusted p-values are from the multivariate regression models adjusted for age and HAM-D covariates.
Correlations between Local Cortical Thickness and Cognitive Functions
Spearman's partial correlation analyses with adjustment for age and HAM-D scores were conducted between the brain regions identified in the cortical thickness analysis and cognitive task scores. Table 4 shows that PD patients demonstrated significant positive correlations between the thickness in the fronto-parieto-temporal areas found in the Bayesian model and the executive functions of set shifting and spontaneous flexibility. Controls failed to show any correlations between thickness and executive functions (p > 0.15).
DISCUSSION
In this study, we adopted for the first time a flexible, hierarchical Bayesian spatial model to test the hypothesis that significant cortical thickness changes (i.e., cortical thinning) occur in PD patients without dementia compared with Controls. This model takes advantage of capturing the short-range correlations between voxels within a defined anatomical region as well as the (potentially) long-range inter-regional correlations. The posterior probability inferences were conducted to compute the contrast probability that an affected voxel exceeds some specified threshold (i.e., 0.9), which does not have to consider multiple tests because there are no false positives [33] , [50] , [51] [52], [53] , [54] , [55] . Note that we also tried linear mixed-effects models with subject-level and region-level random-effects, but there were severe convergence issues for the cases with high-dimensionality of regions (i.e., G ¼ 35). However, the hierarchical Bayesian approach doesn't suffer from this problem and also has the benefit of incorporating a flexible unstructured inter-region correlation matrix and exchangeable intra-region correlations (Fig. 3) . Addtionally, the Bayesian framework enables us to formulate probabilistic statements that help to quantify the evidence provided by our experimental data. The inference framework also allows us to compute Bayesian credible intervals to make statistical inferences. Further, the MCMC estimation procedures produce samples from the joint posterior distribution of all of the model parameters, which facilitates estimation of and inferences about functions of the model parameters. We found that PD patients without dementia displayed a significant association between global cortical thinning and aging, with a higher slope than Controls. In addition, the study demonstrated thinning in a number of specific cortical regions in PD, and this localized cortical thinning was significantly correlated with cognitive decline in PD patients. These results support that cortical thinning occurs in PD patients without dementia and may serve as a predictor for cognitive decline in this population.
Previous MR-based cerebral volume studies have revealed GM atrophy and decline of cognitive impairment in PD [11] , [12] , [13] . VBM analysis of the cerebral cortex, however, can be influenced by GM intensity and cortical folding patterns, and the results of VBM studies in non-demented PD subjects have been variable, and showing regional GM atrophy in frontal, temporal, or parietal cortex [14] , [16] . While useful as an exploratory tool, VBM may not be adequate to detect the concrete anatomical changes occurring in the cerebral cortex. The surface-based cortical thickness analysis minimizes the influence of volume-based methods and provides more direct measurements of gray matter changes and insight into disease pathogenesis [26] . Using the flexible hierarchical Bayesian spatial model, our study revealed the most robust cortical thinning findings reported to date in PD subjects without dementia (Fig. 2) , and these regions show a higher inter-region correlation captured in our model (Fig. 3) . Specifically, our study showed that non-demented PD patients demonstrated widespread cortical thinning in large scale neural networks involving the bilateral inferior and superior parietal regions, including the precuneus, as well as bilateral superior frontal and superior temporal regions compared to Controls. The precuneus has been described as a critical node of information convergence in the parietal network [56] . In addition, PET studies by Eidelberg et al. [9] , [57] demonstrated a "PD-related cognitive pattern" (PDCP) that showed reduced metabolism of the dorsolateral premotor cortex (PMC), rostral supplementary motor area (pre-SMA), precuneus, and other posterior parietal regions, and expressed the correlates with performance on neuropsychological tests of memory and executive functioning in non-demented PD patients. Our study for the first time demonstrated a converging pattern of anatomical frontal-parietal-precuneus thinning that occurs in non-demented PD patients and is related to decline in executive cognitive function. Of note, we utilized the Desikan-Killiany atlas regions from FreeSurfer for analysis, which did not separate the SMA and pre-SMA. From our model in Figs. 2a and 2b , the SMA and pre-SMA near the precentral and postcentral gyri showed strong posterior probability connected to the frontal-parietal-precuneus regions. In addition, the thinning in these regions was related to executive cognitive function. These findings support that neuroimaging-based evidence of structural changes may link to PD cortical pathology and the associated cognitive performance.
PET studies have shown that the greatest cerebral glucose metabolic rate reduction in PD occurs in the occipital lobe [58] . Similarly, Nagamachi et al. [59] demonstrated that the greatest difference in hypoperfusion observed between patients with milder PD (H&Y I and II) and patients with advanced PD (H&Y III and IV) was in the occipital cortex. Our findings suggest that left occipital cortex thinning in PD may reflect those functional changes (either as consequences or causes of these changes). Although we do not have visual specific testing or hallucination scores, it is of interest to determine whether the occipital cortical thinning will be predictive of future risk of visual specific dysfunction and/or hallucinations at later stages of the disease [60] .
Pathologically PD is associated with a degeneration of the substantia nigra pars compacta of the basal ganglia, but it has been postulated that degeneration extends beyond the basal ganglia and affects more widespread brain areas as disease progresses [8] . It is possible that cortical changes in PD are due to primary cortical GM pathology consisting of Lewy bodies and neurites even in early clinical stage patients [8] . Since many of the cortical areas have direct projections to the striatum, it is also possible that the cortical changes reflect progressive cortico-striatal circuitry dysfunction in PD [3] , [13] , which may affect the glucose metabolism in cortical regions as shown in PET studies. The chronic "dis-use", or hypofunction might be underlying the cortical thinning.
As expected, in our study, PD patients without dementia had reduced performance on several neuropsychological tests, particularly involving fine motor speed, processing speed, set-shifting, spontaneous flexibility, and attention (refer to Table 3 ). Impaired fine motor speed and processing speed may have been exaggerated by testing patients in a practically defined "off" treatment state when there is comparatively greater basal ganglia dysfunction. Executive dysfunction in PD frequently has been attributed to dopamine loss in the striatum that may affect frontostriatal functions by disrupting activity within corticobasal ganglia and basal ganglia-thalamocortical circuits [3] , [11] , [12] , [13] . Our MRI cortical thinning analysis, however, also showed that significant morphological brain structural changes occurred in bilateral parietal and superior frontal regions. The current analysis did not reveal group differences in language, spatial cognition, or learning/memory tests. This may be due partly to PD patients in the current study being in early stages of the disease.
We examined the relationship between cortical thinning and cognitive function in PD patients without dementia. The correlations between cortical thinning areas and decline in cognitive domain may extend the understanding of possible pathophysiological substrates underlying PD symptoms. Table 4 shows that moderately strong and statistically significant correlations were found between measures of executive function (including spontaneous flexibility and set-shifting) and cortical thinning in bilateral fronto-parietal regions in the PD sample but not Controls. These regions, including the superior parietal and precuneus, inferior parietal, and superior frontal cortices, have been linked together in a large scale neural network subserving integrative processing for executive functions [54] , [56] , [61] , [62] , [63] . Morphological changes to these regions could contribute to executive function decline separately or in pathophysiologic synergy with basal ganglia dysfunction [64] . In summary, the current results showed that PD patients without dementia sustain cortical thinning that is related to performance reduction in several cognitive domains, with the most robust correlations occurring between fronto-parietal network changes and executive functions.
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